Your browser doesn't support javascript.
loading
Epigenomic profiling of neuroblastoma cell lines.
Upton, Kristen; Modi, Apexa; Patel, Khushbu; Kendsersky, Nathan M; Conkrite, Karina L; Sussman, Robyn T; Way, Gregory P; Adams, Rebecca N; Sacks, Gregory I; Fortina, Paolo; Diskin, Sharon J; Maris, John M; Rokita, Jo Lynne.
Affiliation
  • Upton K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Modi A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Patel K; Genomics and Computational Biology Graduate Group, University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Kendsersky NM; Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Conkrite KL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Sussman RT; Pharmacology Graduate Group, University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Way GP; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Adams RN; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Sacks GI; Genomics and Computational Biology Graduate Group, University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Fortina P; Cancer Genomics and Bioinformatics Laboratory, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, 19107, USA.
  • Diskin SJ; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
  • Maris JM; Cancer Genomics and Bioinformatics Laboratory, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, 19107, USA.
  • Rokita JL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
Sci Data ; 7(1): 116, 2020 04 14.
Article in En | MEDLINE | ID: mdl-32286315
ABSTRACT
Understanding the aberrant transcriptional landscape of neuroblastoma is necessary to provide insight to the underlying influences of the initiation, progression and persistence of this developmental cancer. Here, we present chromatin immunoprecipitation sequencing (ChIP-Seq) data for the oncogenic transcription factors, MYCN and MYC, as well as regulatory histone marks H3K4me1, H3K4me3, H3K27Ac, and H3K27me3 in ten commonly used human neuroblastoma-derived cell line models. In addition, for all of the profiled cell lines we provide ATAC-Seq as a measure of open chromatin. We validate specificity of global MYCN occupancy in MYCN amplified cell lines and functional redundancy of MYC occupancy in MYCN non-amplified cell lines. Finally, we show with H3K27Ac ChIP-Seq that these cell lines retain expression of key neuroblastoma super-enhancers (SE). We anticipate this dataset, coupled with available transcriptomic profiling on the same cell lines, will enable the discovery of novel gene regulatory mechanisms in neuroblastoma.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epigenomics / N-Myc Proto-Oncogene Protein / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Data Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epigenomics / N-Myc Proto-Oncogene Protein / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Sci Data Year: 2020 Document type: Article Affiliation country:
...